Legal & General Group
CAPR icon

Legal & General Group’s Capricor Therapeutics CAPR Stock Holding History

Legal & General Group’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.13M Buy
37,138
+33,169
+836% +$884K ﹤0.01% 2102
2025
Q4 		$115K Sell
3,969
-341
-8% -$4.45K ﹤0.01% 2630
2025
Q3 		$31.1K Sell
4,310
-36,963
-90% -$272K ﹤0.01% 2878
2025
Q2 		$410K Buy
41,273
+3,205
+8% +$33.9K ﹤0.01% 2494
2025
Q1 		$361K Buy
38,068
+7,285
+24% +$101K ﹤0.01% 2500
2024
Q4 		$425K Buy
30,783
+28,058
+1,030% +$492K ﹤0.01% 2516
2024
Q3 		$41.4K Hold
2,725
– – ﹤0.01% 2820
2024
Q2 		$13K Buy
+2,725
New +$15.2K ﹤0.01% 3211

Other funds holding CAPR

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JHC
Jones Hill Capital New York $466M AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return